and negatively with serum albumin (β -0.14, p = 0.033) and creatinine (β -0.18, p = 0.02). Conclusion: Diabetic patients electively starting PD were found to have greater ECW/TBW ratios and ECW excess 6-10 weeks after starting PD compared to non-diabetics, despite similar PET. Increased ECW could predispose diabetic patients to be at greater risk of volume overload.
Introduction
More than 300,000 patients with chronic kidney disease are now treated by peritoneal dialysis (PD) worldwide. Although some of this expansion in PD has been due to a PD first approach adopted by some countries in the Asia-Pacific region, there have been programmes to increase patient uptake in both North America and the United Kingdom. However, the average duration of treatment with PD remains much less than that for haemodialysis, with peritonitis [1] and ultrafiltration failure being the commonest causes of technique failure for patients established on PD [2] . Although PD may incur lower health care treatment costs, episodes of peritonitis and acute transfer to haemodialysis considerably increase health care expenditure [3] . A recent study from North America reported that almost 30% of patients initiating PD changed modality to haemodialysis within the first 90 days [4] .
Diabetic patients have been reported to be at greater risk of modality transfer to haemodialysis [5] . It is unclear as to whether this is due to glucose control or additional co-morbidities associated with diabetes and chronic kidney disease. Diabetic patients established on PD have been reported to have accelerated loss of residual renal function and weight gain, which could be associated with extracellular water (ECW) expansion and ultrafiltration failure [6, 7] .
However, diabetic patients have also been reported to be at risk of early transfer to haemodialysis within the first 90 days of treatment [4] . As such, we wished to review whether there were differences in peritoneal membrane function (PET) and volume assessments in diabetic patients attending their first assessment of PET 6-10 weeks after completing PD training compared to non-diabetic patients.
Patients and Methods
We reviewed the results of consecutive adult patients attending their first assessment of PET between 6 and 10 weeks after completing PD training [8] , who had corresponding bioimpedance assessments. Detailed methods are described in the online supplemental methods section (for all online suppl. material, see www.karger.com/doi/10.1159/000477326). Patients had started PD electively, and none was on an emergency basis; and no patient had suffered peritonitis since starting dialysis.
Patient-related data was obtained from computerised records from the hospital and co-morbidity assessed using the StokeDavies grading scales [9] . This retrospective audit of standard routine clinical practice fulfilled the UK NHS guideline for clinical audit and service development (UK NHS guidelines for clinical audit and service development, available at http://www.hra.nhs. uk/documents/2013/09/defining-research.pdf, and http://www. gov.uk/government/publications/health-research-EthicsCommittees-governancearrangements). All patient data was appropriately anonymised.
Statistical Analysis
Statistical analysis was by t test, or Mann-Whitney U analysis, Anova or Kruskal-Wallis with appropriate post hoc correction for multiple analyses, and by chi-square test or Fisher's exact test. Spearman analysis was used for univariate analysis and ancova for ECW measurements prior to and after starting PD; then non-parametric data was log transformed for multivariable step backward linear analysis, using all variables with a p < 0.1 correlation, with variables excluded if not statistically significant, unless they improved the model fit. Models were checked for variable inflation factor and collinearity (GraphPad Prism version 6.0, San Diego, USA, SPSS 24, University of Chicago, USA). Data is presented as mean ± SD, median (interquartile range) or as a percentage. Statistical significance was considered at p < 0.05.
Results
We reviewed the results of peritoneal membrane testing in 386 adult patients -230 males (59.6%), 152 diabetic (39.4%), mean age 57.3 ± 16.9 years, median timing of PET 8 weeks (6) (7) (8) (9) (10) Diabetic patients were older, and there were more non-white diabetic patients from ( χ 2 = 15.1, p = 0.005; Table 1 ). Although body weight was similar, diabetic subjects had greater body mass index. The mean arterial blood pressure was similar between diabetics and nondiabetics, but diabetic patients were prescribed more anti-hypertensive medications ( χ 2 = 16.8, p = 0.005), and had a higher pulse pressure ( Table 1 ) . Diabetic patients had lower serum cholesterol and triglyceride concentrations and more were prescribed HMG CoA3 reductase inhibitors (statins). C-reactive protein (CRP) concentration and serum albumin were found to be low. Ninety eight (41.9%) non-diabetic patients had grade 1 co-morbidity and 14 (6%) grade 2, compared to 72.4% of diabetics with grade 1 co-morbidity and 27.6% grade 2 ( χ 2 = 121.7, p < 0.001). At 6 months, 84.3% of diabetics remained on PD and 10.5% had transferred to haemodialysis, compared to 86.7% on PD and 4.3% transferred to haemodialysis for the non-diabetics.
As peritoneal clearances may be affected by body size, we analysed the PET separately for male and female patients ( Table 2 ). As expected, male patients had greater weight with greater muscle mass and less body fat. There were no differences in residual renal clearances or peritoneal or total clearance. Female diabetic patients were faster transporters than non-diabetics, but transporter status was similar between male diabetics and non-diabetics. Diabetic patients had greater body fat and increased ECW/total body water (TBW) and excess ECW ( Fig. 1 ). NT-proBNP was higher in male diabetic patients and albumin lower in diabetics, with male diabetics having a lower estimated normalised protein nitrogen appearance rate (nPNA). Diabetic patients had greater comorbidity, but there were no differences between the genders.
Glycated haemoglobin results (reported in mmol/ mol as per guidelines International Federation of Clinical Chemists, IFCC) were available for 347 (89.9%) patients, including all diabetic patients. On univariate analysis, glycated haemoglobin was associated with the mean arterial pressure, pulse pressure, ( Table 3 ) , after excluding variables for collinearity, then pulse pressure, NT-proBNP and the ratio of ECW/TBW remained associated with glycated haemoglobin, whereas IFCC glycated haemoglobin was negatively associated with serum albumin and creatinine ( Table 4 ) . Bioimpedance measurements were available in a subset of 145 patients at the time of training prior to commencing PD, and on ancova testing, comparing starting and then at the time of peritoneal membrane testing ECW/TBW and ECW excess were significantly greater for diabetic patients (f = 12.7, f = 13.1, respectively, p = 0.001). The ratio of ECW/TBW was similar starting PD, but increased for the diabetic cohort (starting 39.2 ± 1.6 vs. 39.1 ± 1.6 and at peritoneal membrane testing 39.4 ± 1.4 vs. 39.1 ± 1.4).
Discussion
Previous reports have shown that while haemodialysis patients have a change in hydration status with dialysis sessions, PD patients generally experience volume expansion with an increased ECW/TBW ratio [10] . However, this ECW expansion does not necessarily reflect increased plasma volume, as ECW excess does not increase peritoneal ultrafiltration [7] or preserve residual renal function [11] . Some studies have suggested that this increase in ECW may be secondary to increased vascular permeability and albumin transfer into interstitial tissues [12] . As such, ECW expansion has been reported to be associated with increased risk of both PD technique failure [2] and patient mortality [13] .
Patients with faster peritoneal transport may be at risk of retaining sodium and fluid due to faster loss of the peritoneal osmotic glucose gradient. We found that female diabetic patients had faster PET transport for creatinine and total proteins, and greater glucose absorption, but there were no such differences noticed in male patients. However, we found no differences in the net sodium balance. Faster transporter status can be secondary to greater intra-peritoneal capillary surface area, which increases with body size, and can also be affected by hyperglycaemia causing vasodilatation [14] . However, the effects of faster transport status can be reduced using icodextrin [15] and the use of APD cyclers with shorter dwell times. As such, more recent studies have not shown an association between faster transporter status in diabetic PD patients and survival [16] . Although other studies have reported an association between faster peritoneal protein transport, which may also be increased by local or systemic inflammation [17] , hyperglycaemia may induce inflammatory vascular changes [14] . Although systolic blood pressure and mean arterial blood pressure were similar between diabetic and non-diabetic patients, our diabetic subjects were prescribed more anti-hypertensive agents and we did note that diabetic patients had increased arterial pulse pressure, suggesting the stiffening of major arteries. Pulse wave velocity has been reported to be greater in PD patients with increased ECW expansion [18] . However, this was a relatively small study and underpowered to determine whether there were similar differences in diabetic patients. Diabetic patients are recognised to be at risk of arterial calcification, and more recently sodium deposition in the vasculature [19, 20] . We found that diabetic patients had lower serum cholesterol and triglyceride concentrations. This may have been due to the high prescription of statins in the diabetic patients, and although diabetic patients used more 22.7 g/L glucose dialysates, they also had a high usage of icodextrin dialysates, with 26.5% also using nutrineal. The combination of icodextrin and nutrineal has been shown to lower both cholesterol and triglycerides in diabetic PD patients [21] . In addition to lower serum cholesterol levels, diabetic patients had lower serum sodium, urea, creatinine and albumin concentrations. Previous reports in PD patients have suggested that fluid retention could lead to a dilutional effect [22] . However, hyperglycaemia can interfere with the standard laboratory measurement of sodium [23] , and once we corrected for the glucose effect, serum sodium concentrations were not different, suggesting that these differences were not simply due to dilution. Lower urea and creatinine concentrations taken along with the lower nPNA could result from suggest lower dietary protein intake and creatinine generation. Some studies have suggested that diabetic patients and those with greater co-morbidity have lower active energy expenditure [24] . Bioimpedance can be used to assess body composition [25] , and we noted that diabetic patients had more body fat, and male diabetic patients had less muscle mass when adjusted to height. Our diabetic patients were older, and body composition can change with age. To minimise age-related changes, we determined ECW excess by comparing measured ECW with that predicted from ICW normative data. Diabetic patients had greater ECW than predicted, and in the subgroup who had starting bioimpedance data, this increased significantly in the diabetic patients since starting PD.
On univariate analysis, glycated haemoglobin was negatively associated with total sodium losses, such that patients with higher IFCC glycated haemoglobin had lower sodium losses, suggesting that they could be at risk of sodium retention. This would be in keeping with the associations between increasing glycated haemoglobin and increased ECW/TBW and N-terminal brain natriuretic peptide (NTproBNP), along with arterial pulse pressure. However, increasing co-morbidity and inflammation have also been observed to increase ECW/TBW and NTproBNP [25] . This interaction would support the association with lower serum albumin, creatinine, and nPNA. However, when analyses were restricted to the diabetic patients alone, then there was no association be- Step backward multivariable analysis using IFCC measurement of glycated haemoglobin, which was log transformed. Unstandardised β (β) and standard error (StE) and standardised β (Stβ), 95% confidence limits. NTproBNP, serum creatinine (creatinine), ECW/TBW tween ECW excess and glycated haemoglobin, suggesting that the association is for diabetics, rather than glucose control per se. There is controversy as to the effect of diabetic control on outcomes in PD patients [26, 27] . The different results reported by studies may be related to confounders including whether single time point measurements of glycated haemoglobin reflect long-term, time-averaged diabetic control, the duration of diabetes and also insulin resistance, so-called pre-diabetes, and additional factors that may specifically affect glycated haemoglobin concentrations in PD patients [28] . Although many diabetic patients with chronic kidney disease are successfully treated by PD [29] , other reports have suggested that diabetic patients are more likely to experience early technique failure and transfer to haemodialysis [4] . Comparing diabetic patients at their first assessment of PET, we found that diabetic patients had evidence of ECW excess compared to non-diabetics, as the measured ECW was greater than the ECW expected for the ICW, suggesting that diabetic patients had greater ECW. This association between ECW expansion and diabetes may potentially increase the risk of technique failure, but this hypothesis would require formal testing in a prospective trial.
